An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Center for Drug Evaluation and Research (CDER)

Office of Infectious Diseases Regulatory Science Activities

2019 Public Workshops

Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease (April 8, 2019)

2018 Public Workshops

Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis (June 27, 2108)
Development of Non-Traditional Therapies for Bacterial Infections (August 21, 2018)

2017 Public Workshops

2016 Public Workshops

Clinical Trial Design Considerations for Malaria Drug Development (June 30, 2016)
Facilitating Antibacterial Drug Development for Patients with Unmet Need and Developing Antibacterial Drugs that Target a Single Species (July 18 and 19, 2016)
Anti-infective Drug Development in Neonates (September 15, 2016)
Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices (September 29, 2016)

Top